• 第三軍醫(yī)大學(xué)西南醫(yī)院普通外科(重慶400038);

引用本文： 余佩武. 胃手術(shù)后胃無(wú)力癥的診斷與治療. 中國(guó)普外基礎(chǔ)與臨床雜志, 1999, 6(3): 172-173. doi: 復(fù)制

版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國(guó)普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. 何三光， 曹起楷， 盧賢庭等. 胃大部切除術(shù)后排空延遲癥. 實(shí)用外科雜志， 1982； 2(5)∶231.
2. 陳紹禮. 胃大部切除術(shù)后功能性排空障礙. 醫(yī)師進(jìn)修雜志， 1996； 19(5)∶39.
3. 劉玉石， 盧光非， 張化東. 殘胃排空延遲癥. 醫(yī)師進(jìn)修雜志， 1991； 14(7)∶22.
4. Gullen JJ, Kelly KA. Gastric motor physiology and pathophysiology. Surg Clin North Am, 1993; 73(6)∶1145.
5. Quigley EMM. Gastric and small intestinal motility in health and disease. Gastroenterol Clin North Am, 1996; 25(1)∶113.
6. Pottros P, Picard M, Dery R, et al. Eveluation of gastric emptying function in clinical practice. Dig Dis Sci, 1997; 42(11)∶2183.
7. Chen JD, Lin ZY, Pan J, et al. Abnormal gastric myoelectrical activity and delayed gastric emptying in paitents with symptoms suggestive of gastroparesis. Dig Dis Sci, 1996; 4(8)∶1538.
8. Patterson DJ, Fracp CF. Prokinetic agents in postgastrectomy patients. Gastroenterol Clin North Am, 1994; 23(2)∶313.
9. Wiseman LR, Faulds D, Cisapride. An update review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs, 1994; 47∶116.
10. Weber FH, Richards RD, McCallum RW. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Am J Gastroenterol, 1993; 88∶485.
11. Mozwecz H, Pavel D, Pitrak D, et al. Erythromycin stearate as prokinetic agent in postvagotomy gastroparesis. Dig Dis Sci, 1992; 35∶407.
12. Karlstrom L, Kelly KA. RouxY gastrectomy for chronic gastric atony. Am J Surg, 1989; 157∶44.
13. Eckhauser FE, Conrad M, Knol JA, et al. Safety and longterm durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome. Am Surg, 1998; 6418∶711.
  1. 1. 何三光， 曹起楷， 盧賢庭等. 胃大部切除術(shù)后排空延遲癥. 實(shí)用外科雜志， 1982； 2(5)∶231.
  2. 2. 陳紹禮. 胃大部切除術(shù)后功能性排空障礙. 醫(yī)師進(jìn)修雜志， 1996； 19(5)∶39.
  3. 3. 劉玉石， 盧光非， 張化東. 殘胃排空延遲癥. 醫(yī)師進(jìn)修雜志， 1991； 14(7)∶22.
  4. 4. Gullen JJ, Kelly KA. Gastric motor physiology and pathophysiology. Surg Clin North Am, 1993; 73(6)∶1145.
  5. 5. Quigley EMM. Gastric and small intestinal motility in health and disease. Gastroenterol Clin North Am, 1996; 25(1)∶113.
  6. 6. Pottros P, Picard M, Dery R, et al. Eveluation of gastric emptying function in clinical practice. Dig Dis Sci, 1997; 42(11)∶2183.
  7. 7. Chen JD, Lin ZY, Pan J, et al. Abnormal gastric myoelectrical activity and delayed gastric emptying in paitents with symptoms suggestive of gastroparesis. Dig Dis Sci, 1996; 4(8)∶1538.
  8. 8. Patterson DJ, Fracp CF. Prokinetic agents in postgastrectomy patients. Gastroenterol Clin North Am, 1994; 23(2)∶313.
  9. 9. Wiseman LR, Faulds D, Cisapride. An update review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs, 1994; 47∶116.
  10. 10. Weber FH, Richards RD, McCallum RW. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Am J Gastroenterol, 1993; 88∶485.
  11. 11. Mozwecz H, Pavel D, Pitrak D, et al. Erythromycin stearate as prokinetic agent in postvagotomy gastroparesis. Dig Dis Sci, 1992; 35∶407.
  12. 12. Karlstrom L, Kelly KA. RouxY gastrectomy for chronic gastric atony. Am J Surg, 1989; 157∶44.
  13. 13. Eckhauser FE, Conrad M, Knol JA, et al. Safety and longterm durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome. Am Surg, 1998; 6418∶711.